Arteriosclerosis and Thrombosis, Vol 13, 1460-1468, Copyright © 1993 by American Heart Association

ARTICLES

Phenotypic variation among familial hypercholesterolemics heterozygous for either one of two Afrikaner founder LDL receptor mutations

MJ Kotze, WJ De Villiers, K Steyn, JA Kriek, AD Marais, E Langenhoven, JS Herbert, JF Graadt Van Roggen, DR Van der Westhuyzen and GA Coetzee
Department of Human Genetics, Faculty of Medicine, University of Stellenbosch, Tygerberg, South Africa.

Two common founder-related gene mutations that affect the low-density lipoprotein receptor (LDLR) are responsible for approximately 80% of familial hypercholesterolemia (FH) in South African Afrikaners. The FH Afrikaner-1 (FH1) mutation (Asp206-->Glu) in exon 4 results in defective receptors with approximately 20% of normal activity, whereas the FH Afrikaner-2 (FH2) mutation (Val408-->Met) in exon 9 completely abolishes LDLR activity (< 2% normal activity). We analyzed the contribution of these mutations and other factors on the variation of hypercholesterolemia and clinical features in Afrikaner FH heterozygotes. The type of FH mutation, plasma triglyceride levels, and age of patients each contributed significantly to the variation in hypercholesterolemia, whereas smoking status, high-density lipoprotein cholesterol levels, and gender had no influence. Although all FH heterozygotes had frank hypercholesterolemia, patients with the FH1 mutation had significantly lower cholesterol levels than those with the FH2 mutation. FH1 heterozygotes also tended to have milder clinical features. The differences between the two FH groups could not be explained by a difference in the common apolipoprotein E variants. This study demonstrates that mutational heterogeneity in the LDLR gene influences the phenotypic expression of heterozygous FH.

This article has been cited by other articles:

				N. A. Patsopoulos, A. Tatsioni, and J. P. A. Ioannidis Claims of Sex Differences: An Empirical Assessment in Genetic Associations JAMA, August 22, 2007; 298(8): 880 - 893. [Abstract] [Full Text] [PDF]

				S E Humphries, R A Whittall, C S Hubbart, S Maplebeck, J A Cooper, A K Soutar, R Naoumova, G R Thompson, M Seed, P N Durrington, et al. Genetic causes of familial hypercholesterolaemia in patients in the UK: relation to plasma lipid levels and coronary heart disease risk J. Med. Genet., December 1, 2006; 43(12): 943 - 949. [Abstract] [Full Text] [PDF]

				M. A. Austin, C. M. Hutter, R. L. Zimmern, and S. E. Humphries Familial Hypercholesterolemia and Coronary Heart Disease: A HuGE Association Review Am. J. Epidemiol., September 1, 2004; 160(5): 421 - 429. [Abstract] [Full Text] [PDF]

				P. Mozas, R. Galetto, M. Albajar, E. Ros, M. Pocovi, and J. C. Rodriguez-Rey A mutation (-49C>T) in the promoter of the low density lipoprotein receptor gene associated with familial hypercholesterolemia J. Lipid Res., January 1, 2002; 43(1): 13 - 18. [Abstract] [Full Text] [PDF]

				F. J. Chaves, J. T. Real, A. B. Garcia-Garcia, M. Civera, M. E. Armengod, J. F. Ascaso, and R. Carmena Genetic Diagnosis of Familial Hypercholesterolemia in a South European Outbreed Population: Influence of Low-Density Lipoprotein (LDL) Receptor Gene Mutations on Treatment Response to Simvastatin in Total, LDL, and High-Density Lipoprotein Cholesterol J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4926 - 4932. [Abstract] [Full Text] [PDF]

				M. Lambert, L. Assouline, J. C. Feoli-Fonseca, N. Brun, E. E. Delvin, and E. Levy Determinants of Lipid Level Variability in French-Canadian Children With Familial Hypercholesterolemia Arterioscler Thromb Vasc Biol, June 1, 2001; 21(6): 979 - 984. [Abstract] [Full Text] [PDF]

				J.T Real, F.J Chaves, I Martinez-Uso, A.B Garcia-Garcia, J.F Ascaso, and R Carmena Importance of HDL cholesterol levels and the total/ HDL cholesterol ratio as a risk factor for coronary heart disease in molecularly defined heterozygous familial hypercholesterolaemia Eur. Heart J., March 2, 2001; 22(6): 465 - 471. [Abstract] [PDF]

				S. Bertolini, A. Cantafora, M. Averna, C. Cortese, C. Motti, S. Martini, G. Pes, A. Postiglione, C. Stefanutti, I. Blotta, et al. Clinical Expression of Familial Hypercholesterolemia in Clusters of Mutations of the LDL Receptor Gene That Cause a Receptor-Defective or Receptor-Negative Phenotype Arterioscler Thromb Vasc Biol, September 1, 2000; 20 (9): e41 - e52. [Abstract] [Full Text] [PDF]

				X.-M. Sun, D. D. Patel, B. L. Knight, and A. K. Soutar Comparison of the Genetic Defect with LDL-Receptor Activity in Cultured Cells from Patients With a Clinical Diagnosis of Heterozygous Familial Hypercholesterolemia Arterioscler Thromb Vasc Biol, November 1, 1997; 17(11): 3092 - 3101. [Abstract] [Full Text]

				A. F. Vuorio, H. Turtola, K.-M. Piilahti, P. Repo, T. Kanninen, and K. Kontula Familial Hypercholesterolemia in the Finnish North Karelia : A Molecular, Clinical, and Genealogical Study Arterioscler Thromb Vasc Biol, November 1, 1997; 17(11): 3127 - 3138. [Abstract] [Full Text]

				A. D. Marais, J. C. Firth, M. E. Bateman, P. Byrnes, C. Martens, and J. Mountney Atorvastatin: An Effective Lipid-Modifying Agent in Familial Hypercholesterolemia Arterioscler Thromb Vasc Biol, August 1, 1997; 17(8): 1527 - 1531. [Abstract] [Full Text]

				U.-M. Koivisto, H. Gylling, T. A. Miettinen, and K. Kontula Familial Moderate Hypercholesterolemia Caused by Asp235->Glu Mutation of the LDL Receptor Gene and Co-occurrence of a De Novo Deletion of the LDL Receptor Gene in the Same Family Arterioscler Thromb Vasc Biol, July 1, 1997; 17(7): 1392 - 1399. [Abstract] [Full Text]

				A. R. Miserez and U. Keller Differences in the Phenotypic Characteristics of Subjects With Familial Defective Apolipoprotein B-100 and Familial Hypercholesterolemia Arterioscler Thromb Vasc Biol, October 1, 1995; 15(10): 1719 - 1729. [Abstract] [Full Text]

				S. Tonstad, T. P. Leren, M. Sivertsen, and L. Ose Determinants of Lipid Levels Among Children With Heterozygous Familial Hypercholesterolemia in Norway Arterioscler Thromb Vasc Biol, August 1, 1995; 15(8): 1009 - 1014. [Abstract] [Full Text]

				J. Ferrieres, J. Lambert, S. Lussier-Cacan, and J. Davignon Coronary Artery Disease in Heterozygous Familial Hypercholesterolemia Patients With the Same LDL Receptor Gene Mutation Circulation, August 1, 1995; 92(3): 290 - 295. [Abstract] [Full Text]

				M J Kotze, L Theart, M Callis, A V Peeters, R Thiart, and E Langenhoven Nonradioactive multiplex PCR screening strategy for the simultaneous detection of multiple low-density lipoprotein receptor gene mutations. Genome Res., June 1, 1995; 4(6): 352 - 356. [Abstract] [PDF]

				J.F. G. van Roggen, D.R. van der Westhuyzen, G.A. Coetzee, A.D. Marais, K. Steyn, E. Langenhoven, and M.J. Kotze FH Afrikaner-3 LDL Receptor Mutation Results in Defective LDL Receptors and Causes a Mild Form of Familial Hypercholesterolemia Arterioscler Thromb Vasc Biol, June 1, 1995; 15(6): 765 - 772. [Abstract] [Full Text]